About Gynecologic Cancer Awareness Month September is recognized nationwide as Gynecologic Cancer Awareness Month. This is a dedicated time to raise awareness for all gynecologic cancers, including ovarian, cervical, uterine, vaginal, and vulvar cancers. Throughout the month, OCRA joins forces with patients, caregivers, and supporters to amplify our voices. We focus on educating the public … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY 2026 Appropriations & Congressional Recess: A Vital Advocacy Window As Congress continues its August recess, this “district and state work period” transforms into a strategic opportunity. Some lawmakers are focused on local engagement like town halls and community meetings, which make it the … Continued
The Rio Grande Valley community will once again come together to ride for research as OCRA’s Ovarian Cycle Rio Grande Valley returns on September 13th at TRYBE Cycle. This year’s event is especially meaningful, marking the 10th anniversary of the fundraiser. Registration is open now. Event chair and ovarian cancer survivor Marlynn Olivarez recently appeared on KRGV-TV Channel 5 News with Dina Herrera Garza, … Continued
Scientists have identified sixteen potential therapeutic targets in low-grade serous ovarian cancer by studying proteins at the molecular level, with results published on August 11, 2025, in the journal Cancer Cell. The research was led by Ernst Lengyel, MD, PhD of University of Chicago, along with Matthias Mann, PhD, of the Max Planck Institute of … Continued
Research Breakthrough: Researchers at the University of Texas MD Anderson Cancer Center identified key gene changes in certain mucinous ovarian cancers with potential to guide care and predict outcomes when identified through genetic testing at diagnosis. Mucinous ovarian cancer is a rare type of ovarian cancer that behaves differently from more common forms, and doctors … Continued
On April 1, 2025, the Rivkin Center for Ovarian Cancer Research officially joined forces with OCRA to expand education, support and research for the ovarian and gynecologic cancer community. Together, we are carrying forward the Rivkin mission to find a cure, honoring stories like Mary’s and working to ensure others have the chance for earlier … Continued
Research Breakthrough: At The University of Chicago, researchers systematically tested existing therapies to find an effective drug combination that shows promise as a treatment for ovarian cancer. Scientists are looking for better ways to treat high-grade serous ovarian cancer, especially the cancer cells that survive standard chemotherapy (carboplatin) and lead to recurrence. In this study, researchers … Continued
OCRA Rivkin Family SummeRun Raises Over $320,000 for Research More than 900 participants gathered at Seattle’s Seward Park for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $320,000 to advance innovative ovarian cancer research. Now in its 32nd year, the beloved 5K run/walk brought together survivors, families, friends, and supporters—all united in … Continued
Written by Chad Ramsey, Vice President, Policy, Ovarian Cancer Research Alliance FY26 Budget & Appropriations Update: Approaching August with Focused Advocacy As Congress advances the FY 2026 appropriations process, gynecologic cancer advocates have a key opportunity to engage. The House has delayed its markup of the Labor, Health and Human Services (Labor-HHS) Appropriations bill until after the … Continued
The 2025 OCRA Rivkin Family SummeRun brought together more than 900 participants in Seattle to raise critical funds for ovarian cancer research. KIRO-TV 7 Seattle (CBS) covered the event in a series of segments that shared its story with viewers across the region. Now in its 32nd year, the SummeRun was held on July 13 … Continued
KZJO-TV Fox 13 Seattle broadcast live all morning from the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun at Seward Park on July 13, 2025, giving viewers a first-hand look at its energy and impact. The 32nd annual event brought together more than 900 survivors, families, and supporters, and raised over $320,000 for innovative ovarian … Continued
More than 900 participants gathered at Seattle’s Seward Park on July 13, 2025, for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun. Now in its 32nd year, the beloved 5K run/walk brought together survivors, families, friends, and supporters—all united in the mission to end ovarian cancer. This year’s event raised more than $320,000 to … Continued
Get email updates about research news, action alerts, and ways to join the fight.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
